The capacity of several potent pharmacological agents to increase growth hormone (GH) release was tested in young (3- to 4-month-old) and old (18- to 20-month-old) male Sprague-Dawley rats. Young and old animals were injected with α-methyl-p-tyrosine (250 mg/kg), a catecholamine synthesis inhibitor, followed 60 min later by the α-adrenergic receptor agonist, clonidine hydrochloride (150 μg/kg). Plasma GH levels increased to greater than 276 ng/ml by 30 and 50 min in young rats, whereas values never exceeded 130 ng/ml (p < 0.01) in old rats. Piribedil methane sulfonate (1 mg/ kg), a dopamine receptor agonist, significantly increased GH in young animals 60 min after injection (p < 0.05), but had no effect in old rats. Morphine sulfate (5 mg/kg) increased plasma GH concentrations in young rats to greater than 400 ng/ml at 30, 50 and 70 min after injection, whereas values in old animals never exceeded 300 ng/ml (p < 0.01). 15 min after injection of somatostatin antiserum No. 774 (5 ml/kg), plasma GH levels increased to greater than 750 ng/ml in both young and old rats. Administration of greater volumes of somatostatin antiserum (8 ml/kg) increased GH levels more in old than in young animals 30 and 45 min after injection (p < 0.01). These results indicate that old male rats have less capacity to increase GH in response to agents that normally enhance GH release. This may be the result of a diminished number or affinity of post-synaptic neurotransmitter receptors, or to an increased release of somatostatin. Since somatostatin antiserum increased GH equally or to a greater extent in old than in young animals, aging rats may release more somatostatin or the pituitary may be more sensitive to the inhibitory effects of this hormone.